Shengke Pharmaceuticals (Jiangsu) Ltd.
PrivateLast Round
Early Funding
Nov 28, 2023
Company Overview
Shengke Pharmaceuticals (Jiangsu) Ltd. is a biopharmaceutical company focused on the discovery and development of targeted small molecule inhibitors for the treatment of cancer and other diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shengke Pharmaceuticals (Jiangsu) Ltd. Comparables
Compare Shengke Pharmaceuticals (Jiangsu) Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eilean Therapeutics | 80% | |
| Binjiang Pharma, Inc. | 79% | |
| Relay Therapeutics | 69% | |
Shengke Pharmaceuticals (Jiangsu) Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Nov 28, 2023 | ||||
| Early Funding | Jul 9, 2020 | ||||
| Angel | Apr 20, 2019 |
Shengke Pharmaceuticals (Jiangsu) Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Shengke Pharmaceuticals (Jiangsu) Ltd.'s valuation, stock price, and market status.